أعرض في EDS

AN OPEN‐LABEL, PHASE 1/2 STUDY OF FRONTLINE BRENTUXIMAB VEDOTIN + ADRIAMYCIN, VINBLASTINE, AND DACARBAZINE IN PAEDIATRIC PATIENTS WITH ADVANCED STAGE HODGKIN LYMPHOMA

التفاصيل البيبلوغرافية
العنوان: AN OPEN‐LABEL, PHASE 1/2 STUDY OF FRONTLINE BRENTUXIMAB VEDOTIN + ADRIAMYCIN, VINBLASTINE, AND DACARBAZINE IN PAEDIATRIC PATIENTS WITH ADVANCED STAGE HODGKIN LYMPHOMA
المؤلفون: R Kobayashi, Yulia Sidi, Francesco Locatelli, M. A Salvino, Franca Fagioli, C Favre, S Epelman, V Odone‐Filho, Mara Albonei Dudeque Pianovski, R. E. Norris, E. J Leonard, F. A. V Luisi, L B De Abreu Lima, Anna Franklin, F Campana, M Zecca
المصدر: Hematological Oncology. 39
بيانات النشر: Wiley, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Dacarbazine, Advanced stage, Hematology, General Medicine, Vinblastine, Internal medicine, Medicine, Hodgkin lymphoma, Open label, business, Brentuximab vedotin, medicine.drug, Paediatric patients
تدمد: 1099-1069
0278-0232
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f9d942c5d3ccef5aa345967a7c7ebba2
https://doi.org/10.1002/hon.37_2879
حقوق: OPEN
رقم الأكسشن: edsair.doi...........f9d942c5d3ccef5aa345967a7c7ebba2
قاعدة البيانات: OpenAIRE
الوصف
تدمد:10991069
02780232